Amyloid β1–40 Quantification in CSF: Comparison between Chromatographic and Immunochemical Methods

Publisher： Karger

E-ISSN： 1421-9824|23|4|246-250

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.23, Iss.4, 2007-02, pp. : 246-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unaltered Plasma Levels of β-Amyloid(1–40) and β-Amyloid(1–42) upon Stimulation of Human Platelets

By  

Dementia and Geriatric Cognitive Disorders, Vol. 16, Iss. 2, 2003-06 ,pp. : 93-97

Karger

Access to resources Recommend Favorite

Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders

By  

Dementia and Geriatric Cognitive Disorders, Vol. 36, Iss. 1-2, 2013-07 ,pp. : 99-110

Karger

Access to resources Recommend Favorite

Neuroinflammation and β Amyloid Deposition in Alzheimer's Disease: In vivo Quantification with Molecular Imaging

By  

Dementia and Geriatric Cognitive Disorders, Vol. 37, Iss. 1-2, 2013-10 ,pp. : 1-18

Karger

Access to resources Recommend Favorite

Decreased CSF-β-Amyloid 42 in Alzheimer’s Disease and Amyotrophic Lateral Sclerosis May Reflect Mismetabolism of β-Amyloid Induced by Disparate Mechanisms

By  

Dementia and Geriatric Cognitive Disorders, Vol. 13, Iss. 2, 2002-02 ,pp. : 112-118

Karger

Access to resources Recommend Favorite

CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 3, 2006-02 ,pp. : 131-138

Karger

Access to resources Recommend Favorite